Plain-English answer
No single source explains Chinese healthcare. NHC materials are useful for health-system capacity, health indicators, and service delivery. NHSA reports are central for basic medical insurance, fund revenue and spending, medical assistance, reimbursement, payment reform, and drug-list policy. NBS yearbooks provide macro and provincial statistical context. NMPA sources are needed for drug, device, diagnostic, and postmarket regulatory questions. China CDC and disease-control sources matter for surveillance and public health. Provincial, municipal, hospital, and procurement sources are often necessary for implementation.
Why source choice matters in China
China's health system is national in ambition and local in operation. Central agencies set major policy direction, but provinces and cities often shape reimbursement details, hospital payment pilots, procurement execution, price schedules, and service delivery. A national figure can be accurate and still insufficient for a product, hospital, province, or patient-access question.
For example, NHSA statistics can show that basic medical insurance enrollment remains above 95 percent and can report fund income and spending. That does not tell a company whether a specific drug is in the NRDL, whether a device is included in local procurement, or whether a hospital department has budget and workflow capacity to adopt a new technology. NHC statistics can show national resources, such as institutions, beds, health professionals, consultations, life expectancy, maternal mortality, and infant mortality. Those figures do not replace province-level or hospital-level analysis.
China healthcare source map
| Source family | Best use | Limits |
|---|---|---|
| NHC | Health-system capacity, service volume, health indicators, public-health administration. | Usually national or sectoral; local execution may differ. |
| NHSA | Insurance enrollment, fund revenue and spending, reimbursement, NRDL, pricing, procurement, payment reform. | National reports may not capture local benefit design or hospital-level access. |
| NBS | Population, demographics, income, regional statistics, macro context, yearbook series. | Not a substitute for specialized health-system or payer data. |
| NMPA | Product registration, drug and device status, regulatory notices, postmarket supervision. | Approval status does not prove reimbursement, procurement, or hospital adoption. |
| China CDC and disease-control agencies | Infectious disease, vaccination, surveillance, prevention, public-health response. | Surveillance data should be checked for case definition, geography, and reporting method. |
| Local sources | Provincial reimbursement, city pilots, tenders, hospital procurement, local implementation. | Harder to collect and compare, but often decisive. |
Specific examples
The 2023 NHC health development statistics reported life expectancy of 78.6 years, maternal mortality of 15.1 per 100,000, infant mortality of 4.5 per 1,000, 1,070,785 medical institutions, 10.17 million hospital beds, nearly 12.49 million healthcare professionals, and 9.55 billion consultations. Those figures are useful for national system scale and health outcomes.
NHSA's 2024 statistical report recorded 1,326.6208 million basic medical insurance participants and stated that coverage was consolidated at 95 percent. It also reported basic medical insurance fund income of 3,491.337 billion yuan and spending of 2,976.403 billion yuan. Those figures are useful for insurance scale and fund operations, but they do not answer every question about reimbursement level, local benefit design, patient cost, or access to a particular product.
How to triangulate
Start with the question. If the question is system capacity, use NHC and NBS. If it is insurance, payment, or procurement, use NHSA and local policy. If it is product approval, use NMPA. If it is disease burden or surveillance, use China CDC, NHC, WHO, and peer-reviewed literature. If it is market access, combine official sources with local implementation evidence, hospital economics, tender records, and interviews.
Research anchors
- NHC 2023 health development statistics for national health indicators and system resources.
- NHSA 2024 medical security statistical report for insurance enrollment and fund data.
- National Bureau of Statistics yearbooks for macro and regional statistical context.
- National Medical Products Administration for drug and medical-device regulatory information.
- WHO China health financing for health-financing context and public insurance coverage.